Digital Access

Digital Access
Access theherald-news.com and all Shaw Media Illinois content from all your digital devices and receive breaking news and updates from around the area.

Home Delivery

Home Delivery
Local news, sports, business, classified and more! News you can use every day.

Text Alerts

Text Alerts
Choose your news! Select the text alerts you want to receive: breaking news, weather, and more.

Email Newsletters

Email Newsletters
Have our latest news, sports and obituaries emailed directly to you Monday through Friday so you can keep up with what's happening in the area.
Local News

State Sen. Rezin focusing on health care costs, protections

Sue Rezin, R-Morris
Sue Rezin, R-Morris

State Sen. Sue Rezin, R-Morris, is sponsoring two recent bills that would tackle health care-related issues.

One of Rezin’s bills would require health insurance companies to offer generic alternatives for EpiPens, the brand name of a device that delivers the lifesaving medication used when someone is experiencing a severe allergic reaction.

Senate Bill 2047 passed the Senate unanimously Thursday, according to a news release. It also would require health insurance companies to offer generic alternatives for insulin auto-injectors.

“These lifesaving drugs can be extremely expensive for those who need them,” Rezin said in the release. “Generic forms are often much more affordable.”

Another one of her bills seeks to provide more protections for individuals with pre-existing conditions by prohibiting the state from applying for a federal waiver that would reduce or eliminate any protection under the Affordable Care Act, unless it is approved by the General Assembly.

“Last year, states were given the option to waive key provisions of the federal health care law,” Rezin said a news release. “The fear is that applying for these waivers could have a detrimental effect on people with pre-existing conditions. I want to give those individuals as much peace of mind as possible that they will not lose their coverage.”

Senate Bill 2026 also was passed last week by the Senate. It will move to the House for consideration.

Loading more